OBJECTIVE: Mutations in the Valosin-containing protein (VCP) gene cause a unique disorder characterized by classic Paget disease of bone (PDB), inclusion body myopathy, and frontotemporal dementia (IBMPFD). Our objective was to analyze the radiographic features of PDB associated with VCP mutations since there is a dearth of literature on the PDB component of VCP disease. MATERIALS AND METHODS: Radiographic bone surveys were examined in 23 individuals with VCP mutation and compared with their unaffected relatives. Laboratory testing relevant for VCP disease was performed in all individuals. RESULTS: Of the 17 affected individuals with clinical manifestations of VCP disease, 16 of whom had myopathy, radiographic analysis revealed classic PDB in 11 individuals (65%). The mean age of diagnosis for myopathy was 43.8 years and for PDB was 38.1 years of age. Radiological evidence of PDB was seen in one individual (16%) amongst six clinically asymptomatic VCP mutation carriers. Alkaline phosphatase was a useful marker for diagnosing PDB in VCP disease. CONCLUSIONS: Radiographic findings of classic PDB are seen in 52% of individuals carrying VCP mutations at a significantly younger age than conventional PDB. Screening for PDB is warranted in at-risk individuals because of the benefit of early treatment with the new powerful bisphosphonates that hold the potential for prevention of disease.
OBJECTIVE: Mutations in the Valosin-containing protein (VCP) gene cause a unique disorder characterized by classic Paget disease of bone (PDB), inclusion body myopathy, and frontotemporal dementia (IBMPFD). Our objective was to analyze the radiographic features of PDB associated with VCP mutations since there is a dearth of literature on the PDB component of VCP disease. MATERIALS AND METHODS: Radiographic bone surveys were examined in 23 individuals with VCP mutation and compared with their unaffected relatives. Laboratory testing relevant for VCP disease was performed in all individuals. RESULTS: Of the 17 affected individuals with clinical manifestations of VCP disease, 16 of whom had myopathy, radiographic analysis revealed classic PDB in 11 individuals (65%). The mean age of diagnosis for myopathy was 43.8 years and for PDB was 38.1 years of age. Radiological evidence of PDB was seen in one individual (16%) amongst six clinically asymptomatic VCP mutation carriers. Alkaline phosphatase was a useful marker for diagnosing PDB in VCP disease. CONCLUSIONS: Radiographic findings of classic PDB are seen in 52% of individuals carrying VCP mutations at a significantly younger age than conventional PDB. Screening for PDB is warranted in at-risk individuals because of the benefit of early treatment with the new powerful bisphosphonates that hold the potential for prevention of disease.
Authors: Micaela Rios Visconti; Anne L Langston; Nerea Alonso; Kirsteen Goodman; Peter L Selby; William D Fraser; Stuart H Ralston Journal: J Bone Miner Res Date: 2010-11 Impact factor: 6.741
Authors: M J Kovach; B Waggoner; S M Leal; D Gelber; R Khardori; M A Levenstien; C A Shanks; G Gregg; M T Al-Lozi; T Miller; W Rakowicz; G Lopate; J Florence; G Glosser; Z Simmons; J C Morris; M P Whyte; A Pestronk; V E Kimonis Journal: Mol Genet Metab Date: 2001-12 Impact factor: 4.797
Authors: Gavin J A Lucas; Sarju G Mehta; Lynne J Hocking; Tracy L Stewart; Tim Cundy; Geoff C Nicholson; John P Walsh; William D Fraser; Giles D J Watts; Stuart H Ralston; Virginia E Kimonis Journal: Bone Date: 2005-09-30 Impact factor: 4.398
Authors: Jouni Vesa; Hailing Su; Giles D Watts; Sabine Krause; Maggie C Walter; Barbara Martin; Charles Smith; Douglas C Wallace; Virginia E Kimonis Journal: Neuromuscul Disord Date: 2009-10-13 Impact factor: 4.296
Authors: Giles D J Watts; Jill Wymer; Margaret J Kovach; Sarju G Mehta; Steven Mumm; Daniel Darvish; Alan Pestronk; Michael P Whyte; Virginia E Kimonis Journal: Nat Genet Date: 2004-03-21 Impact factor: 38.330
Authors: Angèle Nalbandian; Svetlana Ghimbovschi; Shlomit Radom-Aizik; Eric Dec; Jouni Vesa; Barbara Martin; Susan Knoblach; Charles Smith; Eric Hoffman; Virginia E Kimonis Journal: Clin Transl Sci Date: 2012-04-04 Impact factor: 4.689
Authors: Angèle Nalbandian; Katrina J Llewellyn; Mallikarjun Badadani; Hong Z Yin; Christopher Nguyen; Veeral Katheria; Giles Watts; Jogeshwar Mukherjee; Jouni Vesa; Vincent Caiozzo; Tahseen Mozaffar; John H Weiss; Virginia E Kimonis Journal: Muscle Nerve Date: 2012-11-21 Impact factor: 3.217
Authors: Angèle Nalbandian; Sandra Donkervoort; Eric Dec; Mallikarjun Badadani; Veeral Katheria; Prachi Rana; Christopher Nguyen; Jogeshwar Mukherjee; Vincent Caiozzo; Barbara Martin; Giles D Watts; Jouni Vesa; Charles Smith; Virginia E Kimonis Journal: J Mol Neurosci Date: 2011-09-03 Impact factor: 3.444
Authors: S G Mehta; M Khare; R Ramani; G D J Watts; M Simon; K E Osann; S Donkervoort; E Dec; A Nalbandian; J Platt; M Pasquali; A Wang; T Mozaffar; C D Smith; V E Kimonis Journal: Clin Genet Date: 2012-10-04 Impact factor: 4.438
Authors: Cheng Cheng; Lan Weiss; Henri Leinonen; Alyaa Shmara; Hong Z Yin; Timothy Ton; Annie Do; Jonathan Lee; Lac Ta; Eshanee Mohanty; Jesse Vargas; John Weiss; Krzysztof Palczewski; Virginia Kimonis Journal: J Transl Med Date: 2022-01-08 Impact factor: 5.531